Inhibition of sphingosine‐1‐phosphate receptor‐2 attenuates idiopathic pulmonary fibrosis by preventing its binding to dapper1 in bronchial epithelial cells
This article is part of a themed issue Mechanopharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.4/issuetoc.
Authors
- Ming Yang (ORCID: https://orcid.org/0000-0001-7788-3356)
- H Liu (ORCID: https://orcid.org/0000-0001-7942-0777)
- Xinda Zhang
- Yu-Chia Cheng (ORCID: https://orcid.org/0000-0002-6576-6854)
- Hui Shao (ORCID: https://orcid.org/0000-0001-7566-6921)
- Ming Tan (ORCID: https://orcid.org/0000-0001-6565-699X)
- Shu‐Xiang Cui (ORCID: https://orcid.org/0000-0002-4466-6045)
- Shengbiao Wan (ORCID: https://orcid.org/0000-0002-0842-572X)
- Zejia Sun (ORCID: https://orcid.org/0000-0003-1079-3019)
- Xiaonan Zhang (ORCID: https://orcid.org/0000-0001-7664-4222)
- Liang Wang (ORCID: https://orcid.org/0000-0002-5247-6727)
- Xiaoping Wu (ORCID: https://orcid.org/0000-0002-7844-1397)
- Xian‐Jun Qu
- Rui Xu (ORCID: https://orcid.org/0009-0009-8393-4135)
- Shuo Mu (ORCID: https://orcid.org/0009-0004-7810-0690)
Institutions
- Capital Medical University (CN)
- Marine Biomedical Research Institute of Qingdao (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1111/bph.70043
- Citations
- 2
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- National Natural Science Foundation of China